Anixa Biosciences Inc Quarterly Costs and Expenses in USD from Q2 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Anixa Biosciences Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q3 2024.
Anixa Biosciences Inc Costs and Expenses for the quarter ending October 31, 2024 was $3.16M, a 3.67% increase year-over-year.
Anixa Biosciences Inc Costs and Expenses for the twelve months ending October 31, 2024 was $13.8M, a 23.3% increase year-over-year.
Anixa Biosciences Inc annual Costs and Expenses for 2024 was $13.8M, a 23.3% increase from 2023.
Anixa Biosciences Inc annual Costs and Expenses for 2023 was $11.2M, a 19.1% decline from 2022.
Anixa Biosciences Inc annual Costs and Expenses for 2022 was $13.9M, a 1.66% increase from 2021.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$13.8M	$3.16M	+$112K	+3.67%	Aug 1, 2024	Oct 31, 2024	10-K	2025-01-10
Q2 2024	$13.7M	$3.59M	+$748K	+26.3%	May 1, 2024	Jul 31, 2024	10-Q	2024-09-06
Q1 2024	$13M	$3.47M	+$697K	+25.2%	Feb 1, 2024	Apr 30, 2024	10-Q	2024-06-04
Q4 2023	$12.3M	$3.61M	+$1.05M	+41.2%	Nov 1, 2023	Jan 31, 2024	10-Q	2024-03-12
Q3 2023	$11.2M	$3.05M	-$558K	-15.5%	Aug 1, 2023	Oct 31, 2023	10-K	2025-01-10
Q2 2023	$11.8M	$2.84M	+$47K	+1.68%	May 1, 2023	Jul 31, 2023	10-Q	2024-09-06
Q1 2023	$11.7M	$2.77M	-$819K	-22.8%	Feb 1, 2023	Apr 30, 2023	10-Q	2024-06-04
Q4 2022	$12.6M	$2.56M	-$1.32M	-34.1%	Nov 1, 2022	Jan 31, 2023	10-Q	2024-03-12
Q3 2022	$13.9M	$3.61M	-$468K	-11.5%	Aug 1, 2022	Oct 31, 2022	10-K	2024-01-16
Q2 2022	$14.3M	$2.8M	-$1.59M	-36.3%	May 1, 2022	Jul 31, 2022	10-Q	2023-09-06
Q1 2022	$15.9M	$3.59M	+$1.15M	+47.3%	Feb 1, 2022	Apr 30, 2022	10-Q	2023-06-14
Q4 2021	$14.8M	$3.88M	+$1.13M	+41.3%	Nov 1, 2021	Jan 31, 2022	10-Q	2023-03-17
Q3 2021	$13.6M	$4.08M	+$1.83M	+81.8%	Aug 1, 2021	Oct 31, 2021	10-K	2023-01-04
Q2 2021	$11.8M	$4.39M	+$1.95M	+80.1%	May 1, 2021	Jul 31, 2021	10-Q	2022-09-09
Q1 2021	$9.86M	$2.44M	-$233K	-8.73%	Feb 1, 2021	Apr 30, 2021	10-Q	2022-06-10
Q4 2020	$10.1M	$2.75M	+$116K	+4.42%	Nov 1, 2020	Jan 31, 2021	10-Q	2022-03-11
Q3 2020	$9.98M	$2.24M	+$114K	+5.34%	Aug 1, 2020	Oct 31, 2020	10-K	2022-01-04
Q2 2020	$9.86M	$2.44M	+$252K	+11.5%	May 1, 2020	Jul 31, 2020	10-Q	2021-09-01
Q1 2020	$9.61M	$2.67M	-$173K	-6.09%	Feb 1, 2020	Apr 30, 2020	10-Q	2021-06-10
Q4 2019	$9.79M	$2.63M	-$2.35M	-47.2%	Nov 1, 2019	Jan 31, 2020	10-Q	2021-03-11
Q3 2019	$12.1M	$2.13M	-$3.28M	-60.6%	Aug 1, 2019	Oct 31, 2019	10-K	2021-01-07
Q2 2019	$15.4M	$2.18M	-$3.78M	-63.4%	May 1, 2019	Jul 31, 2019	10-Q	2020-09-08
Q1 2019	$19.2M	$2.84M	+$692K	+32.2%	Feb 1, 2019	Apr 30, 2019	10-Q	2020-06-09
Q4 2018	$18.5M	$4.98M	+$3.11M	+166%	Nov 1, 2018	Jan 31, 2019	10-Q	2020-03-09
Q3 2018	$15.4M	$5.41M	+$3.67M	+211%	Aug 1, 2018	Oct 31, 2018	10-K	2020-01-09
Q2 2018	$11.7M	$5.97M	+$3.87M	+185%	May 1, 2018	Jul 31, 2018	10-Q	2019-09-06
Q1 2018	$7.86M	$2.15M	+$939K	+77.5%	Feb 1, 2018	Apr 30, 2018	10-Q	2019-06-12
Q4 2017	$6.92M	$1.87M	+$480K	+34.4%	Nov 1, 2017	Jan 31, 2018	10-Q	2019-03-13
Q3 2017	$6.44M	$1.74M	+$624K	+56.1%	Aug 1, 2017	Oct 31, 2017	10-K	2019-01-11
Q2 2017	$5.81M	$2.09M	+$1.02M	+94.8%	May 1, 2017	Jul 31, 2017	10-Q	2018-09-07
Q1 2017	$4.8M	$1.21M	+$63.6K	+5.54%	Feb 1, 2017	Apr 30, 2017	10-Q	2018-06-11
Q4 2016	$4.73M	$1.39M	-$77.5K	-5.26%	Nov 1, 2016	Jan 31, 2017	10-Q	2018-03-09
Q3 2016	$4.81M	$1.11M	-$64.2K	-5.45%	Aug 1, 2016	Oct 31, 2016	10-K	2018-01-09
Q2 2016	$4.87M	$1.07M	-$511K	-32.2%	May 1, 2016	Jul 31, 2016	10-Q	2017-09-08
Q1 2016	$5.38M	$1.15M	-$1.01M	-46.8%	Feb 1, 2016	Apr 30, 2016	10-Q	2017-05-26
Q4 2015	$6.39M	$1.47M	-$3.81M	-72.1%	Nov 1, 2015	Jan 31, 2016	10-Q	2017-03-16
Q3 2015	$10.2M	$1.18M	-$1.76M	-59.9%	Aug 1, 2015	Oct 31, 2015	10-K/A	2016-12-08
Q2 2015	$12M	$1.59M	+$239K	+17.7%	May 1, 2015	Jul 31, 2015	10-Q	2016-08-19
Q1 2015	$11.7M	$2.16M	-$302K	-12.3%	Feb 1, 2015	Apr 30, 2015	10-Q	2016-05-20
Q4 2014	$12M	$5.28M	+$3.31M	+169%	Nov 1, 2014	Jan 31, 2015	10-Q	2016-02-19
Q3 2014	$8.71M	$2.94M	+$775K	+35.8%	Aug 1, 2014	Oct 31, 2014	10-K	2015-12-23
Q2 2014	$7.94M	$1.35M	-$872K	-39.3%	May 1, 2014	Jul 31, 2014	10-Q	2015-08-18
Q1 2014	$8.81M	$2.46M	+$609K	+32.9%	Feb 1, 2014	Apr 30, 2014	10-Q	2015-05-22
Q4 2013	$8.2M	$1.96M	-$108K	-5.21%	Nov 1, 2013	Jan 31, 2014	10-Q	2015-03-09
Q3 2013	$8.31M	$2.16M	+$445K	+25.9%	Aug 1, 2013	Oct 31, 2013	10-K	2015-01-29
Q2 2013	$7.86M	$2.22M	+$1.33M	+148%	May 1, 2013	Jul 31, 2013	10-Q	2014-09-15
Q1 2013	$6.54M	$1.85M	+$725K	+64.4%	Feb 1, 2013	Apr 30, 2013	10-Q	2014-06-16
Q4 2012	$5.81M	$2.07M	+$736K	+55.1%	Nov 1, 2012	Jan 31, 2013	10-Q	2014-03-17
Q3 2012	$5.07M	$1.72M	+$263K	+18.1%	Aug 1, 2012	Oct 31, 2012	10-K/A	2014-01-17
Q2 2012	$4.81M	$893K	-$765K	-46.2%	May 1, 2012	Jul 31, 2012	10-Q/A	2013-09-20
Q1 2012	$5.58M	$1.13M	-$248K	-18.1%	Feb 1, 2012	Apr 30, 2012	10-Q/A	2013-06-19
Q4 2011	$5.82M	$1.34M	-$207K	-13.4%	Nov 1, 2011	Jan 31, 2012	10-Q/A	2013-03-25
Q3 2011	$6.03M	$1.46M			Aug 1, 2011	Oct 31, 2011	10-K	2013-01-29
Q2 2011		$1.66M	+$330K	+24.8%	May 1, 2011	Jul 31, 2011	10-Q	2012-09-14
Q1 2011		$1.37M			Feb 1, 2011	Apr 30, 2011	10-Q	2012-06-14
Q4 2010		$1.54M			Nov 1, 2010	Jan 31, 2011	10-Q	2012-03-16
Q2 2010		$1.33M			May 1, 2010	Jul 31, 2010	10-Q/A	2011-10-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.